February 26, 2024

PacBio to Present at Upcoming Investor Conferences

MENLO PARK, Calif., Feb. 26, 2024 /PRNewswire/ — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:

  • TD Cowen 44th Annual Health Care Conference on Tuesday, March 5, 2024, at 1:30 PM ET in Boston, MA
  • Barclays 26th Annual Global Healthcare Conference on Tuesday, March 12, 2024, at 10:15 AM ET in Miami Beach, FL

Live webcasts of the events can be accessed at the company’s investors page at Webcast replays will be available for at least 30 days following the event.

About PacBio

PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our HiFi long-read sequencing and our SBB® short-read sequencing technologies. Our products address solutions across a broad set of research applications, including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit and follow @PacBio.

PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.


Todd Friedman

Lizelda Lopez 

SOURCE Pacific Biosciences of California, Inc.

Talk with an expert

If you have a question, need to check the status of an order, or are interested in purchasing an instrument, we're here to help.